WELCOME TO SIT GROUP

SIT - Press Release. SIT and DESMA logos in white, with the text in the middle of the photo stating "SIT Press Release"

SIT acquires NATIFAR and NATIMED from Laboratorios BIAL

SIT Group is pleased to announce the acquisition of Natifar and Natimed brands from Laboratorios BIAL, a Spanish affiliate of BIAL Group (BIAL), as a result of the agreement signed on October 25th, 2022. 

Either products will be distributed by DESMA Spain, which already include in its Spanish portfolio well-known brands in different therapeutic areas like Akineton, Hemicraneal and Proctolog. 

SIT PHARMA acquires OSTIDIL-D3 and KEFORAL

SIT PHARMA is pleased to announce the acquisition of OSTIDIL-D3 and KEFORAL

SIT Pharma acquires DERINOX® for France market

SIT Pharma is pleased to announce the acquisition of DERINOX® from Therabel Lucien Pharma Sas

SIT Pharma acquires MIZOLLEN® for France market

SIT Pharma is pleased to announce the acquisition of MIZOLLEN® from THERABEL HEALTHCARE LIMITED